Journal article Open Access

FUTURE ASPECT OF NANOMEDICINE

Dhanashree B. Midgule, Sutaja L. Ingale, Sayali C. Dudhal, Geetanjali S. Mehetre


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.3362119">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.3362119</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.3362119"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Dhanashree B. Midgule, Sutaja L. Ingale, Sayali C. Dudhal, Geetanjali S. Mehetre</foaf:name>
        <foaf:givenName>Sutaja L. Ingale, Sayali C. Dudhal, Geetanjali S. Mehetre</foaf:givenName>
        <foaf:familyName>Dhanashree B. Midgule</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Department of Pharmaceutical Chemistry ,KasturiShikshanSanstha College of Pharmacy, Shikrapur, Pune-412208. Department of Pharmaceutics, Kasturi Shikshan Sanstha College of Pharmacy, Shikrapur, Pune-412208.</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>FUTURE ASPECT OF NANOMEDICINE</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2019</dct:issued>
    <dcat:keyword>Nano-Sized Colloidal Carriers, Biodistribution, Active Drug (Non-Targeted And Targeted) System, Enhance Effects Etc.</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2019-08-07</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/3362119"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/3362119</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.3362118"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/iajpr"/>
    <dct:description>&lt;p&gt;Nanotechnology is science which focused on the design, synthesis, characterization and application of materials on the nanoscale. The nanotechnologies nowadays are present in many areas of our life, and they will have much impact on the fields of medicine and health care. The world of medicine is very complex, so all of the benefits from nanoscience and nanotechnology to medicine will take time to become evident; however, other benefits will come immediately. Nanomedicine is the improvement and preservation of human health using molecular tools and molecular knowledge of the human body. Nanomedicines future applications will be based on the ability to repair specific diseased cells, functioning in a similar way to antibodies in our natural healing processes. Human health has always been determined on the nanometer scale; this is where the structure and properties of the machines of life work in every one of thecells in every living thing.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.3362119">https://doi.org/10.5281/zenodo.3362119</dcat:accessURL>
        <dcat:byteSize>1072820</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/3362119/files/190708.pdf">https://zenodo.org/record/3362119/files/190708.pdf</dcat:downloadURL>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
32
49
views
downloads
All versions This version
Views 3232
Downloads 4949
Data volume 52.6 MB52.6 MB
Unique views 3232
Unique downloads 4747

Share

Cite as